| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -26756.6% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 3430.8 | n/a |
| Pr/Book | 156.6 |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | -100.0% |
| PBT | n/a | n/a |
| EPS | n/a | -36.4% |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 2.94 | (29.19) | (10.57)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 9.65 | (41.64) | (14.48)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 2.85 | (31.12) | (10.69)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 0.11 | (28.98) | (8.54)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-25 | 0.11 | (36.84) | (9.27)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | n/a | (25.87) | (5.89)p | n/a | n/a | -36% | n/a | 0.0% |
| 31-Dec-27 | n/a | (39.22) | (7.57)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Oversubscribed Strategic Equity Fundraise of ... | 05-Jun-2026 | 07:00 | RNS |
| Block Listing - Application to AIM | 01-Jun-2026 | 15:00 | RNS |
| Clinical data on AVA6000 in salivary gland cancers | 01-Jun-2026 | 07:00 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 69.67p |
| Change Today | -1.83p |
| % Change | -2.56 % |
| 52 Week High | 89.50 |
| 52 Week Low | 29.50 |
| Volume | 1,898,890 |
| Shares Issued | 457.89m |
| Market Cap | £319.00m |
| Beta | 0.01 |
| RiskGrade | 461 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 2 |
| Buy | 0 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 3 |

| No dividends found |
| Time | Volume / Share Price |
| 15:19 | 207 @ 70.68p |
| 15:19 | 888 @ 70.85p |
| 15:17 | 2,500 @ 70.68p |
| 15:16 | 278 @ 70.38p |
| 15:14 | 2 @ 70.90p |
| CEO | Christina Coughlin |
| CFO | Brian Hahn |
You are here: research